Live Webinar - Creating a Resilient Clinical Trial Supply Chain During COVID-19

Date: Wednesday, July, 20, 2022
Time: 11:00 am ET / 4:00 pm BST
Duration: 60 minutes (including Q&A)
Title: The future of clinical trials: How to ensure compliance in a decentralized model
Speakers: 

• Kelly Frend, Personalized Supply Chain Manager, World Courier
• Arnold Bernard, Senior Manager, Specialty Group, World Courier

The impact of the COVID-19 pandemic continues to resonate in every sector. Biopharma is no exception. Supply chains have been strained to breaking point. Clinical trials have been suspended or reconfigured. The assumptions underpinning distribution models have been overturned.

Under considerable pressure to sustain some sort of ‘business as usual’ – and mitigate the impact on patients’ lives – the industry had to find alternative ways of working, such as utilizing new routes and adjusting study protocols, including a rise in demand for direct-to-patient delivery for clinical trials.

As part of our response to this unique situation, World Courier undertook research to better understand customers’ perceptions of the impact of the pandemic. Chief among our findings was a major shift to decentralized trials, and a possible permanent move away from just-in-time distribution.

During this presentation, World Courier’s Kelly Frend, Personalized Supply Chain Manager, and Arnold Bernard, Senior Manager, Specialty Group, will explore the direct-to-patient delivery model for clinical trials as well as new decentralization dispense models and the impact on how drugs and treatments are administered. They will assess the importance of examining the potential implications of a decentralized model, emphasizing compliance requirements and data protection.